Global Cardiac Biomarkers Market 2014-2018

心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン

◆タイトル:Global Cardiac Biomarkers Market 2014-2018
◆商品コード:IRTNTR4572
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年11月5日
◆ページ数:105
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Five UserUSD3,300 ⇒換算¥356,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、種類別分析、需要先別分析、主要地域別分析、主要国別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Cardiac Biomarker
A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.

TechNavio’s analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases.
The market is segmented based on the following type of assay:
• Troponin (cTnI and cTnT)
• BNP & NT-proBNP
• CK-MB
• Myogloblin
• Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L)
TechNavio’s report, the Global Cardiac Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cardiac Biomarkers market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Laboratories
• Alere
• Ortho Clinical Diagnostics
• Roche Diagnostics

[Other Prominent Vendors]
• AniBiotech
• Axis-Shield
• Beckman Coulter
• Becton, Dickinson and Co.
• BG Medicine
• Biomerieux
• Boston Scientific
• Critical Diagnostics
• diaDexus
• LifeSign
• Mitsubishi Chemical Europe
• Nanomix
• Radiometer Medical
• Randox Laboratories
• Response Biomedical
• Siemens Healthcare
• Sierra Resources International
• Singulex
• Thermo Scientific
• Trinity Biotech

[Market Driver]
• Growing Incidence of Cardiac Disorders
• For a full, detailed list, view our report

[Market Challenge]
• Lack of Specific Measures to Detect Presence of CVDs
• For a full, detailed list, view our report

[Market Trend]
• Identification of New Cardiac Biomarkers
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Assay
08. Global Troponin Assay Market
08.1 Introduction
08.2 Market Overview
08.3 Market Size and Forecast
09. Global BNP & NT-proBNP Assay Market
09.1 Introduction
09.2 Market Overview
09.3 Market Size and Forecast
10. Global CK-MB Assay Market
10.1 Introduction
10.2 Market Size and Forecast
11. Global Myogloblin Assay Market
11.1 Introduction
11.2 Market Size and Forecast
12. Market Segmentation by End-user
12.1 Global Cardiac POC Testing Market
12.1.1 Introduction
12.1.2 Market Overview
12.1.3 Market Size and Forecast
12.1.4 Geographical Segmentation
12.2 Global Troponin Market in POC Setting
12.2.1 Market Overview
12.2.2 Market Size and Forecast
12.3 Global BNP & NT-proBNP Market in POC Setting
12.3.1 Market Overview
12.3.2 Market Size and Forecast
13. Global Cardiac Laboratory Testing Market
13.1.1 Introduction
13.1.2 Market Overview
13.1.3 Market Size and Forecast
13.1.4 Geographical Segmentation
13.2 Global Troponin Market in Laboratory Setting
13.2.1 Market Overview
13.2.2 Market Size and Forecast
13.3 Global BNP & NT-proBNP Market in Laboratory Setting
13.3.1 Market Overview
13.3.2 Market Size and Forecast
14. Geographical Segmentation
14.1 Cardiac Biomarkers Market in the Americas
14.1.1 Market Size and Forecast
14.1.2 Cardiac Biomarkers Market in the US
14.2 Cardiac Biomarkers Market in the EMEA Region
14.2.1 Market Size and Forecast
14.2.2 Cardiac Biomarkers Market in Europe
14.3 Cardiac Biomarkers Market in the APAC Region
14.3.1 Market Size and Forecast
14.3.2 Cardiac Biomarkers Market in China
15. Key Leading Countries
15.1 US
15.2 China
16. Buying Criteria
17. Market Growth Drivers
18. Drivers and their Impact
19. Market Challenges
20. Impact of Drivers and Challenges
21. Market Trends
22. Trends and their Impact
23. Vendor Landscape
23.1 Competitive Scenario
23.1.1 Key News
23.1.2 Mergers and Acquisitions
23.2 Market Share Analysis 2013
23.3 Other Prominent Vendors
24. Key Vendor Analysis
24.1 Abbott Laboratories
24.1.1 Key Facts
24.1.2 Business Overview
24.1.3 Business Segmentation by Revenue
24.1.4 Business Segmentation by Revenue 2011 and 2012
24.1.5 Geographical Segmentation by Revenue
24.1.6 Business Strategy
24.1.7 Key Information
24.1.8 SWOT Analysis
24.2 Alere
24.2.1 Key Facts
24.2.2 Business Overview
24.2.3 Business Segmentation by Revenue 2013
24.2.4 Business Segmentation by Revenue 2012 and 2013
24.2.5 Geographical Segmentation by Revenue 2013
24.2.6 Business Strategy
24.2.7 Recent Developments
24.2.8 SWOT Analysis
24.3 Ortho-Clinical Diagnostics
24.3.1 Key Facts
24.3.2 Business Overview
24.3.3 Key Developments
24.3.4 SWOT Analysis
24.4 Roche Diagnostics
24.4.1 Key Facts
24.4.2 Business Overview
24.4.3 Business Segmentation by Revenue 2013
24.4.4 Geographical Segmentation by Revenue 2013
24.4.5 Business Strategy
24.4.6 Recent Developments
24.4.7 SWOT Analysis

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Cardiac Biomarkers Market 2013-2018 (US$ million)
Exhibit 3: Global Cardiac Biomarkers Market Segmentation by Type of Assay
Exhibit 4: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013 & 2018 (US$ million)
Exhibit 5: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013
Exhibit 6: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2018
Exhibit 7: YoY Growth Rate of Global Cardiac Biomarkers Market Segments by Type of Assay 2013-2018
Exhibit 8: Global Cardiac Biomarkers Market Segmentation Snapshot by Type of Assay
Exhibit 9: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013-2018 (US$ million)
Exhibit 10: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013-2018
Exhibit 11: Characteristics of Cardiac Biomarkers
Exhibit 12: Global Troponin Assay Market 2013-2018 (US$ million)
Exhibit 13: Global BNP & NT-proBNP Assay Market 2013-2018 (US$ million)
Exhibit 14: Global CK-MB Assay Market 2013-2018 (US$ million)
Exhibit 15: Global Myogloblin Assay Market 2013-2018 (US$ million)
Exhibit 16: Global Cardiac Biomarkers Market Segmentation by End-user
Exhibit 17: Global Cardiac Biomarkers Market Segmentation by End-user 2013 & 2018 (US$ million)
Exhibit 18: Global Cardiac Biomarkers Market Segmentation by End-user 2013 (Revenue)
Exhibit 19: Global Cardiac Biomarkers Market Segmentation by End-user 2018 (Revenue)
Exhibit 20: Global Cardiac Biomarkers Market Segmentation by End-user 2013-2018 (US$ million)
Exhibit 21: Global Cardiac Biomarkers Market Segmentation by End-user 2013-2018
Exhibit 22: YoY Growth Rate of Global Cardiac Biomarkers Market Segments by End-user 2013-2018
Exhibit 23: Global Cardiac Biomarkers Market Segmentation Snapshot by End-user
Exhibit 24: Global Cardiac POC Testing Market Segmentation by Assay Type
Exhibit 25: Global Cardiac POC Testing Market Segmentation by Assay Type 2013
Exhibit 26: Global Cardiac POC Testing Market Segmentation by Assay Type 2018
Exhibit 27: Global Cardiac POC Testing Market Segmentation by Assay Type 2013-2018 (US$ million)
Exhibit 28: Global Cardiac POC Testing Market Segmentation by Assay Type 2013-2018
Exhibit 29: Global Cardiac POC Testing Market Segmentation Snapshot by Assay Type
Exhibit 30: Global Cardiac POC Testing Market 2013-2018 (US$ million)
Exhibit 31: Global Cardiac POC Testing Market by Geographical Segmentation 2013
Exhibit 32: Global Cardiac POC Testing Market by Region/Country 2013
Exhibit 33: Global Troponin Market in POC Setting 2013-2018 (US$ million)
Exhibit 34: Global BNP & NT-proBNP Market in POC Setting 2013-2018 (US$ million)
Exhibit 35: Global Cardiac Laboratory Testing Market Segmentation by Assay Type
Exhibit 36: Global Cardiac Laboratory Testing Market 2013
Exhibit 37: Global Cardiac Laboratory Testing Market 2018
Exhibit 38: Global Cardiac Laboratory Testing Market 2013-2018 (US$ million)
Exhibit 39: Global Cardiac Laboratory Testing Market 2013-2018
Exhibit 40: Global Cardiac Laboratory Testing Market Segmentation Snapshot by Assay Type
Exhibit 41: Global Cardiac Laboratory Testing Market 2013-2018 (US$ million)
Exhibit 42: Global Cardiac Laboratory Testing Market by Geographical Segmentation 2013
Exhibit 43: Global Troponin Market in Laboratory Setting 2013-2018 (US$ million)
Exhibit 44: Global BNP & NT-proBNP Market in Laboratory Setting 2013-2018 (US$ million)
Exhibit 45: Global Cardiac Biomarkers Market by Geographical Segmentation 2013
Exhibit 46: Global Cardiac Biomarkers Market by Region/Country 2013
Exhibit 47: Geographical Segmentation of Global Cardiac Biomarkers Market by End-user 2013
Exhibit 48: YoY Growth Rate of Regions/Countries in Global Cardiac Biomarkers Market by End-user 2013-2018
Exhibit 49: Cardiac Biomarkers Market in the Americas 2013-2018 (US$ million)
Exhibit 50: Cardiac Biomarkers Market in the US 2013-2018 (US$ million)
Exhibit 51: Cardiac Biomarkers Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 52: Cardiac Biomarkers Market in Europe 2013-2018 (US$ million)
Exhibit 53: Cardiac Biomarkers Market in the APAC Region 2013-2018 (US$ million)
Exhibit 54: Cardiac Biomarkers Market in China 2013-2018 (US$ million)
Exhibit 55: Global Cardiac POC Testing Market Share Analysis 2013
Exhibit 56: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 57: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 58: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 59: Alere: Business Segmentation by Revenue 2013
Exhibit 60: Alere: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 61: Alere: Geographical Segmentation by Revenue 2013
Exhibit 62: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 63: Roche Diagnostics: Geographical Segmentation by Revenue 2013



【掲載企業】

Abbott Laboratories, Alere , Ortho Clinical Diagnostics , Roche Diagnostics , AniBiotech , Axis-Shield, Beckman Coulter , Becton, Dickinson and Co., BG Medicine, Biomerieux, Boston Scientific , Critical Diagnostics, diaDexus, LifeSign, Mitsubishi ChemicalEurope, Nanomix , Radiometer Medical, Randox Laboratories , Response Biomedical, Siemens Healthcare, Sierra Resources International, Singulex, Thermo Scientific, Trinity Biotech

【資料のキーワード】

心臓バイオマーカー、心疾患検査、トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン、急性冠症候群、医療機器、治療

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン] (Global Cardiac Biomarkers Market 2014-2018 / IRTNTR4572)販売に関する免責事項
[心臓バイオマーカーの世界市場:トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビン] (Global Cardiac Biomarkers Market 2014-2018 / IRTNTR4572)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆